1 / 13

Surgical management of liver haemangioma

Surgical management of liver haemangioma. Dr Chris Yau Dept of Surgery PWH. 68 F USG: 3cm hyperechoic lesion right lobe Typical haemangioma Hepatitis marker –ve, AFP CEA normal FU CT scan: 7cm after 3 yr Trisegmentectomy: cholangiocarcinoma. 67 F USG: 4cm lesion left lobe

shaunna
Download Presentation

Surgical management of liver haemangioma

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Surgical management of liver haemangioma Dr Chris Yau Dept of Surgery PWH

  2. 68 F USG: 3cm hyperechoic lesion right lobe Typical haemangioma Hepatitis marker –ve, AFP CEA normal FU CT scan: 7cm after 3 yr Trisegmentectomy: cholangiocarcinoma 67 F USG: 4cm lesion left lobe Typical haemangioma Hepatitis marker, AFP CEA normal FU USG 1 yr 8cm mass left lobe, multiple satellite lesions right lobe Palliative care Clinical scenario --- pitfall

  3. Content • Pathology • Prevalence / Etiology • Clinical presentation • Diagnostic tools • Surveillance • Surgical management • Take home message

  4. Liver Haemangioma --Pathology • First prescribed by Amboise Pare 1570 (Paris) • Benign tumour • Size up to 30cm • Giant Haemangioma ifsize > 10cm

  5. Liver Haemangioma --Pathology • Microscpically: • large endothelium lined vascular channels packed with red blood cell • Macroscopically: • red wine colored mass with lobulated appearance

  6. Prevelance / Etiology • 0.7% to 7.3 % in autopsy finding * • Female predominance 1.5 – 6 : 1 ** • Present most often between 3rd and 4th decade • Positive correlation with female sex hormone *Belghiti, Management of haemangioma, Stuttgart: 1993: 78-85 ** Yan et al, US guided percutanceous RFA for hepatic haemangioma. World J Gastroenterol, 2003 Sept 2132-2134

  7. Clinical Presentation • Asymptomatic • Epigastric pain • Spontaneous hemorrhage • Traumatic hemorrhage • Cardiac failure

  8. Dignostic tools • USG: • Homogenous hyperechoic • CT scan: • Pre-contrast: Relative hypodense • Early phase : Perilesional increase in contrast • Delayed: isodense / hyperdense

  9. Diagnostic tools • MRI scan: • T1 : hypointense • T2 : heavily hyperintense • Arteriography: • Golden standard • Cotton Wool appearance

  10. Gandolfi (Italy) Nippon (Japan) Leifer (US) No of pt 123 23 383 Drop out NA Nil 170 Follow up period 12-60 months 12-114 months 12 yrs Change of lesion 1 Nil NA Malignancy Nil Nil 1 Complications Nil Nil NA Surveillance

  11. Surgical Treatment • Treatment method: • Laparoscopic Vs Open • Resection Vs Enucleation • RFA • Indications of Surgery • Uncertain diagnosis • Symptomatic • Lesion with documented increase in size • +/- Giant haemangioma

  12. Yoon et al Moreno et al Farges et al Ozden et No of pt 115 26 163 42 Surgery 52 15 8 42 Conservative tx 63 11 155 0 Malignancy 0 0 0 0 Morbidity 25% 13% NA 12% Mortality 0 0 NA 2.4% Surgery result

  13. Take home message • Majority haemangioma can be treated conservatively • Existence of mimicker • Repeat scan / FNAC / Surgery if uncertain diagnosis

More Related